Perseus Proteomics Inc. (4882.T)

JPY 610.0

(-0.65%)

Net Debt Summary of Perseus Proteomics Inc.

  • Perseus Proteomics Inc.'s latest annual net debt in 2023 was -1.54 Billion JPY , up 36.95% from previous year.
  • Perseus Proteomics Inc.'s latest quarterly net debt in 2024 Q1 was -2.12 Billion JPY , down -37.91% from previous quarter.
  • Perseus Proteomics Inc. reported annual net debt of -2.44 Billion JPY in 2022, up 23.95% from previous year.
  • Perseus Proteomics Inc. reported annual net debt of -3.21 Billion JPY in 2021, down -200.65% from previous year.
  • Perseus Proteomics Inc. reported quarterly net debt of -1.86 Billion JPY for 2023 Q2, up 8.37% from previous quarter.
  • Perseus Proteomics Inc. reported quarterly net debt of -1.54 Billion JPY for 2023 Q4, up 7.34% from previous quarter.

Annual Net Debt Chart of Perseus Proteomics Inc. (2023 - 2019)

Historical Annual Net Debt of Perseus Proteomics Inc. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -1.54 Billion JPY 36.95%
2022 -2.44 Billion JPY 23.95%
2021 -3.21 Billion JPY -200.65%
2020 -1.06 Billion JPY -121.85%
2019 -482 Million JPY 0.0%

Peer Net Debt Comparison of Perseus Proteomics Inc.

Name Net Debt Net Debt Difference
Kyowa Kirin Co., Ltd. -378.83 Billion JPY 99.593%
Astellas Pharma Inc. 670.02 Billion JPY 100.23%
Chugai Pharmaceutical Co., Ltd. -445.21 Billion JPY 99.654%
Ono Pharmaceutical Co., Ltd. -157.27 Billion JPY 99.02%
Santen Pharmaceutical Co., Ltd. -59.42 Billion JPY 97.406%
JCR Pharmaceuticals Co., Ltd. 4.54 Billion JPY 133.922%
Daiichi Sankyo Company, Limited -259.26 Billion JPY 99.405%
Otsuka Holdings Co., Ltd. -299.15 Billion JPY 99.485%